HbA1c is a reliable test for type 2 diabetes in primary care irrespective of chronic kidney disease

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Shipman, Kate E ^a   Jawad, Mohammed ^a   Sullivan, Katie M ^a   Ford, Clare ^a   Gama, Rousseau ^a  

^a NEW CROSS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; GLYCOSYLATED HEMOGLOBIN;

CHRONIC KIDNEY DISEASE; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; END STAGE RENAL DISEASE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN ANALYSIS; HUMAN; LETTER; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; MALE; METABOLISM; NOTE;

DIABETES MELLITUS, TYPE 2; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE;

EID: 84902602750     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3780     Document Type: Letter

References (5)

1. NHS Information Centre. Health Survey for England - 2009. Health and lifestyles. 2009. http://data.gov.uk/dataset/health-survey-for-england-2009- health-and-lifestyles.
2. 1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1 Geneva, World Health Organization, 2011.
3. 1c to diagnose type 2 diabetes or to identify people at high risk of diabetes. BMJ 2014;348:g2867. (25 April.)
4. 1C of patients with diabetes and chronic kidney disease. Diabetes Care 2010;33:2310-3.
5. Shipman KE, Jawad M, Sullivan KM, Ford C, Gama R. Effect of chronic kidney disease on a1c in individuals being screened for diabetes. Prim Care Diab 2014; published online 9 Feb.